COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 122 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,409,000 | +5.9% | 93,041 | +20.1% | 0.00% | 0.0% |
Q4 2018 | $1,330,000 | -41.5% | 77,464 | -49.7% | 0.00% | +100.0% |
Q3 2018 | $2,272,000 | +31.3% | 154,072 | +112.4% | 0.00% | -50.0% |
Q2 2018 | $1,730,000 | +0.9% | 72,552 | +8.1% | 0.00% | 0.0% |
Q1 2018 | $1,714,000 | +39.6% | 67,088 | +0.8% | 0.00% | 0.0% |
Q4 2017 | $1,228,000 | +95.9% | 66,533 | +11.3% | 0.00% | +100.0% |
Q3 2017 | $627,000 | -15.8% | 59,794 | +0.3% | 0.00% | 0.0% |
Q2 2017 | $745,000 | +146.7% | 59,590 | +98.8% | 0.00% | – |
Q1 2017 | $302,000 | -23.7% | 29,973 | +17.8% | 0.00% | -100.0% |
Q4 2016 | $396,000 | -4.6% | 25,437 | +18.1% | 0.00% | 0.0% |
Q3 2016 | $415,000 | +62.7% | 21,545 | 0.0% | 0.00% | – |
Q2 2016 | $255,000 | +25.0% | 21,545 | +91.5% | 0.00% | – |
Q1 2016 | $204,000 | -23.0% | 11,249 | +16.6% | 0.00% | – |
Q4 2015 | $265,000 | +24.4% | 9,649 | 0.0% | 0.00% | – |
Q3 2015 | $213,000 | +23.8% | 9,649 | 0.0% | 0.00% | – |
Q2 2015 | $172,000 | – | 9,649 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |